SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Xetra Frankfurt
Börse Xetra Frankfurt
ISIN US717081ER06
EUR
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US717081ER06
Symbol PFE
Währung EUR
Börse Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39  . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

1.789 News & Informationen zur Pfizer Aktie

  • The 20 best-performing IPOs of the past three years have returned up to 1,477%
    marketwatch.com

    The 20 best-performing IPOs of the past three years have returned up to 1,477%

    These stock-market winners include BioNTech, Zoom, CrowdStrike and Nio.

  • Brazil and Russia see fresh wave of COVID cases, showing pandemic is far from over in many places
    marketwatch.com

    Brazil and Russia see fresh wave of COVID cases, showing pandemic is far from over in many places

    Brazil counted a record number of new cases of COVID-19 on Thursday, while Russia saw its highest tally since late January, highlighting the unequal state of…

  • Exclusive: WHO estimates COVID-19 boosters needed yearly for most vulnerable By Reuters
    investing.com

    Exclusive: WHO estimates COVID-19 boosters needed yearly for most vulnerable By Reuters

    Exclusive: WHO estimates COVID-19 boosters needed yearly for most vulnerable

  • WHO estimates COVID-19 booster shots needed yearly for most vulnerable
    livemint.com

    WHO estimates COVID-19 booster shots needed yearly for most vulnerable

    The estimate is included in a report, which is to be discussed on Thursday at a board meeting of Gavi, a vaccine alliance that co-leads the WHO's COVID-19 vaccine programme COVAX

  • 2 Bargain Stocks You Can Buy Right Now
    fool.com

  • Is Pfizer Stock Still A Buy In 2021? (NYSE:PFE)
    seekingalpha.com

    Is Pfizer Stock Still A Buy In 2021? (NYSE:PFE)

    Pfizer commercializes one of the best COVID drugs with BioNTech, but it is not a vaccine-focused company. See if PFE stock is still a buy in 2021

  • BAYER AG : UBS reaffirms its Buy rating
    marketscreener.com

    BAYER AG : UBS reaffirms its Buy rating

    Analyst Michael Leuchten from UBS research considers the stock attractive and recommends it with a Buy rating. The target price continues to be set at EUR 85. | June 24, 2021

  • Pfizer Declares Third-Quarter 2021 Dividend
    news.google.com

    Pfizer Declares Third-Quarter 2021 Dividend

    Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a 39-cent third-quarter 2021 dividend on the company’s common stock, paya

  • Pfizer Declares Third-Quarter 2021 Dividend
    thestreet.com

    Pfizer Declares Third-Quarter 2021 Dividend

    Pfizer Inc. PFE today announced that its board of directors declared a 39-cent third-quarter 2021 dividend on the company's common stock, payable September 7,

  • Pfizer (PFE) Begins Dosing in Prostate Cancer Drugs Study
    zacks.com

    Pfizer (PFE) Begins Dosing in Prostate Cancer Drugs Study

    Pfizer (PFE) is developing its oral PARP inhibitor, talazoparib (Talzenna), in combination with Xtandi as a potential treatment for castration-sensitive prostate cancer in a late-stage study.

  • Active Pharmaceutical Ingredient Market Revenue To Reach ~$300 Billion by 2030: P&S Intelligence
    prnewswire.com

    Active Pharmaceutical Ingredient Market Revenue To Reach ~$300 Billion by 2030: P&S Intelligence

    /PRNewswire/ — The global active pharmaceutical ingredient (API) market is set for rapid expansion in the coming years, primarily because of the increasing…

  • Pfizer: Excellent Potential for Double-Digit Return (NYSE:PFE)
    seekingalpha.com

    Pfizer: Excellent Potential for Double-Digit Return (NYSE:PFE)

    At its current price levels, an investment in Pfizer represents a wide moat business for sale at a fair price. Click here to read about the valuation and PT for the stock.

  • Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
    prnewswire.com

    Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action

    /PRNewswire/ — Viatris (NASDAQ: VTRS) today announced that the U.S. District Court for the District of Kansas ruled, in substantial part, in Mylan's favor on…

  • U.S. administers 319.9 million doses of COVID-19 vaccines
    investing.com

    U.S. administers 319.9 million doses of COVID-19 vaccines

    U.S. administers 319.9 million doses of COVID-19 vaccines – CDC

  • Worldwide Pain Management Drugs Industry To 2026 - Featuring Abbott Laboratories, Pfizer And Allergen Among Others
    thestreet.com

    Worldwide Pain Management Drugs Industry To 2026 – Featuring Abbott Laboratories, Pfizer And Allergen Among Others

    DUBLIN, June 23, 2021 /PRNewswire/ — The “Pain Management Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”

  • Why Moderna and BioNTech Stocks Slipped Today
    fool.com

    Why Moderna and BioNTech Stocks Slipped Today

    Data was presented to a CDC advisory panel suggesting a link between mRNA vaccines and heart inflammation issues in young men.

  • S&P 500 Dips, Nasdaq Ekes Out Record; Hawkish Fed Talk Continues By Investing.com
    investing.com

    S&P 500 Dips, Nasdaq Ekes Out Record; Hawkish Fed Talk Continues By Investing.com

    S&P 500 Dips, Nasdaq Ekes Out Record; Hawkish Fed Talk Continues

  • NIH begins clinical trial testing COVID-19 vaccine in pregnant women By Reuters
    investing.com

    NIH begins clinical trial testing COVID-19 vaccine in pregnant women By Reuters

    NIH begins clinical trial testing COVID-19 vaccine in pregnant women

  • Constituent
    investopedia.com

    Constituent

    A constituent is a single stock or company that is part of a larger index such as the S&P 500 or Dow Jones Industrial Average.

  • S&P 500 Flat as Tech Takes Breather; Fed's Bostic Talks Up Earlier Rate Hikes By Investing.com
    investing.com

    S&P 500 Flat as Tech Takes Breather; Fed's Bostic Talks Up Earlier Rate Hikes By Investing.com

    S&P 500 Flat as Tech Takes Breather; Fed's Bostic Talks Up Earlier Rate Hikes

  • Forget Dogecoin: These Growth Stocks Are a Smarter Bets By StockNews
    investing.com

    Forget Dogecoin: These Growth Stocks Are a Smarter Bets By StockNews

    Forget Dogecoin: These Growth Stocks Are a Smarter Bets

  • Outlook on the Malignant Ascites Global Market to 2029 - Featuring Pfizer, Novartis and GI Supply Among Others
    prnewswire.com

    Outlook on the Malignant Ascites Global Market to 2029 – Featuring Pfizer, Novartis and GI Supply Among Others

    /PRNewswire/ — The “Malignant Ascites Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies…

  • Serendipity, Pfizer Stock And A Value Investment (NYSE:PFE)
    seekingalpha.com

    Serendipity, Pfizer Stock And A Value Investment (NYSE:PFE)

    Pfizer's patent cliff and political risk are priced in already but high levels of R&D investment and the mRNA technology have vast potential.

  • Illicit covid-19 drugs bound for Mexico seized by US authorities
    livemint.com

    Illicit covid-19 drugs bound for Mexico seized by US authorities

    Possibly counterfeit or generic versions of Gilead’s remdesivir are reaching U.S. via airports

  • 8 Hot Biotech Penny Stocks For Your July 2021 Watch List
    pennystocks.com

  • Illicit COVID-19 drugs bound for Mexico seized by US authorities
    foxbusiness.com

    Illicit COVID-19 drugs bound for Mexico seized by US authorities

    Criminal activity is on the uprise in U.S. airports, where federal authorities continue to seize illegal COVID-19 drugs trying to make their way to Mexico.

  • Delta variant of SARS-CoV-2 is now in 85 countries and accounts for 20% of U.S. infections in past two weeks
    marketwatch.com

    Delta variant of SARS-CoV-2 is now in 85 countries and accounts for 20% of U.S. infections in past two weeks

    The delta variant of COVID-19 has now been detected in 85 countries, according to the World Health Organization, and remains a variant of concern with…

  • Factbox: How GSK plans to fire-up its cash balance post split By Reuters
    investing.com

    Factbox: How GSK plans to fire-up its cash balance post split By Reuters

    Factbox: How GSK plans to fire-up its cash balance post split

  • Pfizer Stock: Worth A Hold But Needs Growth (NYSE:PFE)
    seekingalpha.com

    Pfizer Stock: Worth A Hold But Needs Growth (NYSE:PFE)

    Pfizer doesn't appear to be on track to overcome some of its pre-pandemic hurdles to growth. Read about the challenges with Pfizer stock here.

  • Global Coronavirus Vaccine Market to Surpass US$ 95,988.0 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Coronavirus Vaccine Market to Surpass US$ 95,988.0 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, June 23, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global coronavirus vaccine market is estimated to be valued at US$…

  • Pfizer Doses First Participant In TALAPRO-3, Placebo-controlled Phase 3 Clinical Trial - Quick Facts
    markets.businessinsider.com

    Pfizer Doses First Participant In TALAPRO-3, Placebo-controlled Phase 3 Clinical Trial – Quick Facts

    (RTTNews) – Pfizer Inc. (PFE) announced Wednesday that the first participant has been dosed in TALAPRO-3, a global, randomized, double-blind, plac…

  • Pfizer Says First Patient Dosed in Phase 3 Prostate-Cancer Trial
    marketscreener.com

    Pfizer Says First Patient Dosed in Phase 3 Prostate-Cancer Trial

    By Matt Grossman

    Pfizer Inc. said Wednesday that the first patient has been dosed in a Phase 3 trial of the use of its talazoparib drug as a treatment for men with a form of prostate cancer…. | June 23, 2021

  • Glaxo Plans Spinoff for Consumer Unit, 30% Cut to Dividend
    bloombergquint.com

    Glaxo Plans Spinoff for Consumer Unit, 30% Cut to Dividend

    (Bloomberg) — GlaxoSmithKline Plc said it will carve out its consumer unit via a spinoff and cut its dividend by about 30%, outlining details of its plan to break up the business for the first time.

  • How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
    fool.com

    How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges

    Bad news for AstraZeneca and CureVac should mean more good news for Pfizer and Moderna.

  • Illicit Covid-19 Drugs Bound for Mexico Seized by U.S. Authorities
    online.wsj.com

    Illicit Covid-19 Drugs Bound for Mexico Seized by U.S. Authorities

    Counterfeit or generic versions of remdesivir, an antiviral manufactured by Gilead Sciences, are arriving in the U.S. by plane from Bangladesh and India and being smuggled by individuals to Mexico.

  • Sosei Heptares Initiates Phase 1 Trial With Novel Small-Molecule CGRP Antagonist Under Collaboration With Biohaven
    thestreet.com

    Sosei Heptares Initiates Phase 1 Trial With Novel Small-Molecule CGRP Antagonist Under Collaboration With Biohaven

    TOKYO and CAMBRIDGE, England, June 23, 2021 /PRNewswire/ — Sosei Group Corporation (“the Company”; TSE: 4565) today announces that the first healthy subject

  • Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in Europe By Reuters
    investing.com

    Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in Europe By Reuters

    Analysis: From game-changer to back-up: J&J's COVID vaccine struggles in Europe

  • Brazil probes $320m deal for Covaxin jabs
    timesofindia.indiatimes.com

    Brazil probes $320m deal for Covaxin jabs

    International Business News: Brazilian federal prosecutors have opened an investigation into a contract worth 1.

  • AstraZeneca vaccine effective against Covid-19 variants identified in India
    thehindubusinessline.com

    AstraZeneca vaccine effective against Covid-19 variants identified in India

    Company cites study by Oxford University

  • 4 Trending Health Care Stocks To Watch Right Now
    entrepreneur.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba